ArticleDEN open2027
Improved Efficiency and Lesion Detection in Small Bowel Capsule Endoscopy Using the Open-Source Artificial Intelligence Model SEE-AI.
Article in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Small bowel capsule endoscopy (CE) produces lengthy videos that are time-consuming to review and susceptible to missed lesions. We evaluated whether an open-source, pretrained artificial intelligence (AI) model (SEE-AI) could improve diagnostic performance and interpretation efficiency compared with conventional reading. Methods: We retrospectively analyzed 249 PillCam SB3 examinations performed between 2007 and 2022 at six hospitals, using a two-reader crossover design. SEE-AI (confidence threshold 0.1) generated annotated videos with bounding boxes for eight lesion categories. The primary endpoints were sensitivity for lesion detection on a per-lesion and per-patient basis. Secondary endpoints included specificity, predictive values, overall accuracy, and reading time. A prespecified subgroup analysis evaluated cases of suspected small-bowel bleeding (SSBB), focusing on Saurin P1+P2 hemorrhagic lesions. Results: Across 1550 adjudicated lesions, AI-assisted reading demonstrated higher sensitivity than conventional reading (per-lesion: 98.8% [1532/1550] vs. 86.4% [1339/1550]; per-patient: 99.1% [464/468] vs. 80.3% [376/468]; both Conclusions: In this multicenter evaluation, SEE-AI significantly improved lesion detection and reduced reading time for CE interpretation, including SSBB cases, while maintaining openness and reproducibility. AI-assisted reading may reduce clinicians' workload and support the adoption of SEE-AI as a practical tool - and a potential future standard of care - for small bowel CE. Trial Registration: N/A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.